The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Cevac Meta L lyophilisate for oculonasal suspension for chickens

CEVA-Phylaxia Veterinary Biologicals Co. LtdVPA10463/003/001

Main Information

Trade NameCevac Meta L lyophilisate for oculonasal suspension for chickens
Active SubstancesAvian metapneumovirus, subtype B, CRR126 strain
Dosage FormLyophilisate for oculonasal suspension/use in drinking water
Licence HolderCEVA-Phylaxia Veterinary Biologicals Co. Ltd
Licence NumberVPA10463/003/001

Group Information

ATC CodeQI01AD01 avian rhinotracheitis virus
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued11/11/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back